Search Results

There are 7343 results for: content related to: Structural and Functional Basis for the Long QT Syndrome: Relevance to Veterinary Patients

  1. Clinical Relevance and Management of Drug-Related QT Interval Prolongation

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 23, Issue 7, July 2003, Pages: 881–908, Dr. Michael A. Crouch, Dr. Lynn Limon and Dr. Angela T. Cassano

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.23.7.881.32730

  2. You have free access to this content
    Long QT syndrome: reduced repolarization reserve and the genetic link

    Journal of Internal Medicine

    Volume 259, Issue 1, January 2006, Pages: 59–69, D. M. RODEN

    Version of Record online : 29 NOV 2005, DOI: 10.1111/j.1365-2796.2005.01589.x

  3. Dynamics of Acquired Long QT Syndrome

    Dynamic Electrocardiography

    Elijah R. Behr, A. John Camm, Pages: 406–416, 2007

    Published Online : 25 OCT 2007, DOI: 10.1002/9780470987483.ch40

  4. Risk of QT Prolongation and Torsades de Pointes with Antimicrobial and Antimalarial Drugs

    Acquired Long QT Syndrome

    A. John Camm, Yee Guan Yap, Marek Malik, Pages: 121–139, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470994771.ch8

  5. You have free access to this content
    Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development

    British Journal of Pharmacology

    Volume 159, Issue 1, January 2010, Pages: 34–48, Vaibhav Salvi, Dilip R Karnad, Gopi Krishna Panicker and Snehal Kothari

    Version of Record online : 23 SEP 2009, DOI: 10.1111/j.1476-5381.2009.00427.x

  6. Drug-Induced QT-Interval Prolongation: Considerations for Clinicians

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 7, July 2010, Pages: 684–701, Dr. Edward C. Li, Dr. John S. Esterly, Dr. Shaunte Pohl, Dr. Shane D. Scott and Dr. Brian F. McBride

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.30.7.684

  7. Risk of QT Prolongation and Torsades de Pointes with Psychotropic Drugs

    Acquired Long QT Syndrome

    A. John Camm, Yee Guan Yap, Marek Malik, Pages: 102–120, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470994771.ch7

  8. Inherited Long QT Syndromes:

    Journal of Cardiovascular Electrophysiology

    Volume 10, Issue 12, December 1999, Pages: 1664–1683, DAN M. RODEN and PETER M. SPOONER

    Version of Record online : 20 APR 2007, DOI: 10.1111/j.1540-8167.1999.tb00231.x

  9. Risk of QT Prolongation and Torsades de Pointes with Prokinetics and Miscellaneous other Drugs

    Acquired Long QT Syndrome

    A. John Camm, Yee Guan Yap, Marek Malik, Pages: 140–162, 2007

    Published Online : 16 NOV 2007, DOI: 10.1002/9780470994771.ch9

  10. You have free access to this content
    Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts

    British Journal of Pharmacology

    Volume 154, Issue 7, August 2008, Pages: 1528–1537, A Sugiyama

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.240

  11. High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia

    British Journal of Clinical Pharmacology

    Volume 82, Issue 2, August 2016, Pages: 504–511, Paula Andrea Moreno-Gutiérrez, Andrés Gaviria-Mendoza, Mauricio Montoya Cañón and Jorge Enrique Machado-Alba

    Version of Record online : 21 MAY 2016, DOI: 10.1111/bcp.12969

  12. Torsade de pointes induced by systemic antifungal agents: lessons from a retrospective analysis of published case reports

    Mycoses

    Volume 49, Issue 6, November 2006, Pages: 463–470, Dan Justo and David Zeltser

    Version of Record online : 3 OCT 2006, DOI: 10.1111/j.1439-0507.2006.01278.x

  13. The Long QT Syndrome and Torsade De Pointes

    Pacing and Clinical Electrophysiology

    Volume 22, Issue 1, January 1999, Pages: 91–110, NABIL EL-SHERIF and GIOIA TURITTO

    Version of Record online : 30 JUN 2006, DOI: 10.1111/j.1540-8159.1999.tb00305.x

  14. You have free access to this content
    Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives

    British Journal of Pharmacology

    Volume 159, Issue 1, January 2010, Pages: 58–69, Rashmi R Shah

    Version of Record online : 25 JUN 2009, DOI: 10.1111/j.1476-5381.2009.00191.x

  15. Cellular Mechanisms, Molecular Targets, and Structure–Function Relationships in Drug-Induced Arrhythmias: Antihistamines, Psychoactive Drugs, and Antimicrobial Agents

    Cardiotoxicity of Non-Cardiovascular Drugs

    Maria Virginia Soldovieri, Maurizio Taglialatela, Pages: 47–96, 2010

    Published Online : 9 APR 2010, DOI: 10.1002/9780470660379.ch3

  16. Drug-Induced Torsades de Pointes and Implications for Drug Development

    Journal of Cardiovascular Electrophysiology

    Volume 15, Issue 4, April 2004, Pages: 475–495, ROBERT R. FENICHEL, MAREK MALIK, CHARLES ANTZELEVITCH, MICHAEL SANGUINETTI, DAN M. RODEN, SILVIA G. PRIORI, JEREMY N. RUSKIN, RAYMOND J. LIPICKY, LOUIS R. CANTILENA and Independent Academic Task Force

    Version of Record online : 13 APR 2004, DOI: 10.1046/j.1540-8167.2004.03534.x

  17. QTc-Interval Prolongation Associated with Slow Intravenous Erythromycin Lactobionate Infusions in Critically Ill Patients: A Prospective Evaluation and Review of the Literature

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 4, July-August 1996, Pages: 663–674, Suzanne J. Tschida, David R.P. Guay, Robert J. Straka, Lori L. Hoey, Rebecca Johanning and Kyle Vance-Bryan

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb03650.x

  18. QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

    Medicinal Research Reviews

    Volume 25, Issue 2, March 2005, Pages: 133–166, Maurizio Recanatini, Elisabetta Poluzzi, Matteo Masetti, Andrea Cavalli and Fabrizio De Ponti

    Version of Record online : 16 AUG 2004, DOI: 10.1002/med.20019

  19. Risk Assessment for Antimicrobial Agent-Induced QTc Interval Prolongation and Torsades de Pointes

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 3, March 2001, Pages: 301–319, Robert C. Owens Jr.

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.21.3.301.34206

  20. You have free access to this content
    International Life Sciences Institute (Health and Environmental Sciences Institute, HESI) initiative on moving towards better predictors of drug-induced torsades de pointes

    British Journal of Pharmacology

    Volume 154, Issue 7, August 2008, Pages: 1491–1501, A S Bass, B Darpo, A Breidenbach, K Bruse, H S Feldman, D Garnes, T Hammond, W Haverkamp, C January, J Koerner, C Lawrence, D Leishman, D Roden, J P Valentin, M A Vos, Y-Y Zhou, T Karluss and P Sager

    Version of Record online : 29 JAN 2009, DOI: 10.1038/bjp.2008.279